Compare WNC & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WNC | SOPH |
|---|---|---|
| Founded | 1985 | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.2M | 374.1M |
| IPO Year | 2009 | 2021 |
| Metric | WNC | SOPH |
|---|---|---|
| Price | $7.56 | $5.29 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $11.00 | $7.50 |
| AVG Volume (30 Days) | ★ 633.6K | 84.8K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.84% | N/A |
| EPS Growth | ★ 179.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,027,489,000.00 | N/A |
| Revenue This Year | $10.65 | $23.09 |
| Revenue Next Year | $14.06 | $19.57 |
| P/E Ratio | $1.50 | ★ N/A |
| Revenue Growth | ★ 8.81 | N/A |
| 52 Week Low | $7.10 | $2.59 |
| 52 Week High | $12.94 | $5.70 |
| Indicator | WNC | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 34.55 | 60.42 |
| Support Level | N/A | $4.56 |
| Resistance Level | $9.48 | $5.30 |
| Average True Range (ATR) | 0.49 | 0.27 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 19.57 | 67.33 |
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.